PSMA-Targeted Therapy May Decrease PSA Levels in Metastatic Prostate Cancer Subset

by admin_63069 | May 22, 2023 | News You Can Use

Patients with metastatic castration-resistant prostate cancer treated with radioligand therapy, a form of targeted therapy, had improvements in PSA levels and survival with favorable side effect profiles.